- We are the Pharma Journal directory
Non-alcoholic fatty liver disease (NAFLD) has evolved into one of the most pressing global health concerns of the 21st century. Closely linked to rising rates...
A new experimental Alzheimer’s drug called donanemab is generating major excitement as a potential breakthrough in treating the disease. In a large-scale clinical trial sponsored...